MedTrace Logo

Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit

NCT06109740 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-10-31

No results posted yet for this study

Summary

The goal of this prospective trial is to learn about lactobacillus use in critically ill pediatric patients. The main question\[s\] it aims to answer are:

* Is lactobacillus GG effective in preventing antibiotic associated diarrhea in the PICU
* Is lactobacillus safe in critically ill pediatric patients Participants will be randomized to lactobacillus GG vs placebo while on antibiotics

If there is a comparison group: Researchers will compare lactobacillus GG to see if it prevents antibiotic associated diarrhea.

Conditions

  • Critical Illness
  • Antibiotic-associated Diarrhea

Interventions

DIETARY_SUPPLEMENT

lactobacillus GG

probiotic

Sponsors & Collaborators

  • Amerifit Brands Inc

    collaborator INDUSTRY

  • University of South Alabama

    lead OTHER

Principal Investigators

  • Allison Chung · University of South Alabama

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
1 Day
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-10-31
Completion
2012-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06109740 on ClinicalTrials.gov